专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US07033624B2 Preventative and treatment effects of Morinda citrifolia on osteoarthritis and its related conditions 失效
标题翻译： Morinda citrifolia对骨关节炎的预防和治疗作用及其相关条件
公开(公告)号：US07033624B2
公开(公告)日：2006-04-25
申请号：US10285359
申请日：2002-10-31
申请人： Claude Jarakae Jensen , Afa Kehaati Palu
发明人： Claude Jarakae Jensen , Afa Kehaati Palu
IPC分类号： A61K35/78
CPC分类号： A61K36/746 , A23L2/02 , A23L33/105
摘要： The present invention embraces methods for improved treatment of osteoarthritis by featuring a naturaceutical formulation or composition for treating osteoarthritis and its associated or related conditions. The present invention further features methods of treating osteoarthritis and its related conditions. In particular, the present invention relates to providing a treatment for osteoarthritis that includes one or more processed products described below as derived and produced from the Indian Mulberry plant, scientifically known as Morinda citrifolia L.
摘要翻译：本发明包括用于改善治疗骨关节炎的方法，其特征在于用于治疗骨关节炎及其相关或相关病症的营养制剂或组合物。本发明还涉及治疗骨关节炎及其相关病症的方法。特别地，本发明涉及提供骨关节炎的治疗，其包括由印度桑树植物衍生和生产的一种或多种加工产品，其被科学地称为海巴戟天（Morinda citrifolia L.）

2. 发明授权

US06855354B2 Freeze concentration process 失效
标题翻译：冻结浓缩过程
公开(公告)号：US06855354B2
公开(公告)日：2005-02-15
申请号：US10044158
申请日：2002-01-11
申请人： Claude Jarakae Jensen , Brett J. West , Robert V. Ogden , Stephen P. Story
发明人： Claude Jarakae Jensen , Brett J. West , Robert V. Ogden , Stephen P. Story
IPC分类号： A23L2/12 , A61K36/746 , B01D9/04 , A61K35/78
CPC分类号： B01D9/04 , A23L2/12 , A61K36/746
摘要： The use of an improved method for freeze concentration is disclosed. The method provides for first freezing components of a pulpy slurry of Morinda citrifolia. More dilute components are extracted after the initial freezing. A secondary freezing process at a lower temperature allows more concentrated portions of a Morinda citrifolia slurry to be removed. Flavor and therapeutic oils remain in the resulting concentrate for improved flavor and health benefits.
摘要翻译：公开了使用改进的冷冻浓缩方法。该方法提供了Morinda citrifolia的浆状浆料的第一冷冻组分。最初冷冻后，提取更多的稀释组分。在较低温度下的二次冷冻过程允许除去海巴戟天泥浆的更多浓缩部分。风味和治疗油保留在所得浓缩物中以改善风味和健康益处。

3. 发明授权

US07186422B2 Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions 失效
标题翻译： Morinda citrifolia对糖尿病及其相关病症的预防和治疗作用
公开(公告)号：US07186422B2
公开(公告)日：2007-03-06
申请号：US10993883
申请日：2004-11-19
申请人： Claude Jarakae Jensen , Afa Kehaati Palu , Hifumi Ohishi , Hisanori Tani
发明人： Claude Jarakae Jensen , Afa Kehaati Palu , Hifumi Ohishi , Hisanori Tani
IPC分类号： A61K36/746 , A61K36/00
CPC分类号： A61K36/746
摘要： The present invention features a unique, natural formulation and method of administering the same to treat and prevent diabetes, or rather advances treatment of diabetes, by providing a naturaceutical composition or treatment formulated with one or more processed Morinda citrifolia products as derived from the Indian Mulberry plant. The Morinda citrifolia is particularly adapted to treat Type II diabetes. The Morinda citrifolia product is preferably a leaf extract, but may also be in the form of a juice, a puree juice, a dietary fiber, or other similar forms and is incorporated into various carriers or naturaceutical compositions suitable for in vivo treatment of a patient. The naturaceutical may also combine other food products into the naturaceutical, such as fruit juices, dietary supplements, vitamins and minerals, and others.
摘要翻译：本发明的特征在于其独特的天然配方和方法，其用于治疗和预防糖尿病，或者改进预防糖尿病，通过提供由一种或多种加工的Morinda citrifolia产品配制的营养组合物或治疗剂，其衍生自印度桑树厂。 Morinda citrifolia特别适用于治疗II型糖尿病。海巴戟天产品优选是叶提取物，但也可以是果汁，果汁，膳食纤维或其它类似形式的形式，并且被掺入适合于体内治疗患者的各种载体或营养组合物中。该制品也可以将其他食品结合到食品中，例如果汁，膳食补充剂，维生素和矿物质等。

4. 发明授权

US07070813B2 Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor 失效
公开(公告)号：US07070813B2
公开(公告)日：2006-07-04
申请号：US10285334
申请日：2002-10-31
申请人： Claude Jarakae Jensen , Afa Kehaati Palu , Stephen P. Story , Summer Jensen , Chen Su
发明人： Claude Jarakae Jensen , Afa Kehaati Palu , Stephen P. Story , Summer Jensen , Chen Su
IPC分类号： A61K35/78
CPC分类号： A61K36/746
摘要： The present invention features methods and formulations or compositions for the treatment of colon cancer, and particularly for the inhibition, prevention and/or reduction of cancerous cell growth, as well as the destruction of early stage cancerous cells within the colon region of a mammal, wherein the formulations and compositions comprise an identified amount or concentration of a processed Morinda citrifolia product or an active ingredient there from, as obtained from the Indian Mulberry plant.

5. 发明授权

US07048952B2 Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice 有权
标题翻译：用于抑制真菌和微生物生长的制剂，其包含烟酸柠檬酸果泥汁
公开(公告)号：US07048952B2
公开(公告)日：2006-05-23
申请号：US10439596
申请日：2003-05-16
申请人： Scott Gerson , Afa Kehaati Palu , Bing-Nan Zhou , Chen Su , Claude Jarakae Jensen , Stephen P. Story , Robert V. Ogden
发明人： Scott Gerson , Afa Kehaati Palu , Bing-Nan Zhou , Chen Su , Claude Jarakae Jensen , Stephen P. Story , Robert V. Ogden
IPC分类号： A61K35/78
CPC分类号： A61K36/746
摘要： The present invention relates to antifungal and antibacterial activity of processed Morinda citrifolia products, as well as from various fractions of extracts from these processed products and the Morinda citrifolia L. plant, and related methods to determine mean inhibitory concentrations. In particular, the present invention relates to ethanol, methanol and ethyl acetate extracts from Morinda citrifolia L. and their inhibitory activities on common fungi and bacteria and the identification of mean inhibitory concentrations.
摘要翻译：本发明涉及加工的海巴戟天产品的抗真菌和抗菌活性，以及来自这些加工产品的提取物和Morinda citrifolia L.植物的各种级分，以及确定平均抑制浓度的相关方法。特别地，本发明涉及来自海巴戟天的乙醇，甲醇和乙酸乙酯提取物及其对常见真菌和细菌的抑制活性以及平均抑制浓度的鉴定。

6. 发明授权

US08535741B2 Method and composition for administering bioactive compounds derived from Morinda citrifolia 有权
标题翻译：用于施用源自海巴戟天的生物活性化合物的方法和组合物
公开(公告)号：US08535741B2
公开(公告)日：2013-09-17
申请号：US13246619
申请日：2011-09-27
申请人： Bing-Nan Zhou , Chen Su , Afa K. Palu , Brett J. West , Shixin Deng , Claude Jarakae Jensen , Stephen Story
发明人： Bing-Nan Zhou , Chen Su , Afa K. Palu , Brett J. West , Shixin Deng , Claude Jarakae Jensen , Stephen Story
IPC分类号： A61K36/746 , A61K36/00
CPC分类号： A61K36/746 , A61K31/409 , A61K2236/00
摘要： This invention relates to a method and composition for providing in various health benefits by administering various bioactive compounds derived from the plant Morinda cirtrifolia to individuals. This invention relates to using one or more of the following: Noni Leaf Extract; Noni Leaf Juice; and/or Roast Leaf More particularly this invention relates to administering one or more of the following: Pyro-phorbide a, Pheophorbide a, Purpin 7, and/or Pheophorbide all which may be derived from Noni leaf extract, Noni leaf juice, and/or Roast leaf Moreover, the foregoing formulations result in alleviating pain and inflammation.
摘要翻译：本发明涉及通过向个体施用衍生自植物Morinda cirtrifolia的各种生物活性化合物来提供各种健康益处的方法和组合物。本发明涉及使用以下一种或多种：非叶提取物; 诺丽叶汁和/或烤叶更具体地，本发明涉及施用一种或多种以下物质：可以衍生自Noni叶提取物，Noni叶汁和/或其中的一种或多种Pyro-Phorbide a，Pheophorbide a，Purpin 7和/或Phe- 另外，上述配方还能减轻疼痛和炎症。

7. 发明授权

US07122211B2 Methods for manufacturing an enhanced cosmetic skin care toner 失效
标题翻译：制造增强美容护肤调色剂的方法
公开(公告)号：US07122211B2
公开(公告)日：2006-10-17
申请号：US09836870
申请日：2001-04-17
申请人： Claude Jarkae Jensen , Heidi Robinson
发明人： Claude Jarkae Jensen , Heidi Robinson
IPC分类号： A61K6/00 , A61K36/00
CPC分类号： A61Q19/00 , A61K8/97 , A61Q19/005 , A61Q19/007 , A61Q19/08 , Y10S514/848
摘要： The present invention advances prior art toners by providing a toner formulated with Morinda Citrifolia, or Noni, from the Indian Mulberry plant. The addition of Noni to the toner of the present invention serves to provide significant skin care advantages not found in prior art toners.
摘要翻译：本发明通过提供与来自印度桑树植物的Morinda Citrifolia或Noni配制的调色剂来改进现有技术的调色剂。将Noni添加到本发明的调色剂中用于提供在现有技术的调色剂中没有发现的显着的皮肤护理优点。

8. 发明授权

US07014873B2 Method and formulation for treating candidiasis using morinda citrifolia 失效
公开(公告)号：US07014873B2
公开(公告)日：2006-03-21
申请号：US10294089
申请日：2002-11-14
申请人： Brett Justin West , Claude Jarakae Jensen , Afa Kehaati Palu , Robert V. Ogden , Scott Gerson
发明人： Brett Justin West , Claude Jarakae Jensen , Afa Kehaati Palu , Robert V. Ogden , Scott Gerson
IPC分类号： A61K35/78
CPC分类号： A61K36/746
摘要： The present invention features a novel use of processed ingredients from the Indian mulberry plant, and particularly a novel use of one or more processed Morinda citrifolia-based naturaceutical formulations comprising one or more of a processed Morinda citrifolia fruit juice, puree juice, oil or oil extract, dietary fiber, alcohol extract, etc., for inhibiting and preventing the overgrowth of Candida fungus and for treating Candidiasis and its associated symptoms.

9. 发明授权

US08501245B2 Selectively inhibiting estrogen production and providing estrogenic effects in the human body 失效
标题翻译：选择性地抑制雌激素的产生并在人体内提供雌激素作用
公开(公告)号：US08501245B2
公开(公告)日：2013-08-06
申请号：US10808872
申请日：2004-03-24
申请人： Mian Ying Wang , Chen Xing Su , Afa Kehaati Palu , Bing-Nan Zhou , Brett Justin West , Johannes Joseph Westendorf , Claude Jarakae Jensen , Stephen Paul Story
发明人： Mian Ying Wang , Chen Xing Su , Afa Kehaati Palu , Bing-Nan Zhou , Brett Justin West , Johannes Joseph Westendorf , Claude Jarakae Jensen , Stephen Paul Story
IPC分类号： A61K36/00
CPC分类号： A61K36/746 , A61K31/353
摘要： Implementation is directed to selectively inhibiting estrogen production and providing estrogenic effects in a human body. A dietary supplement includes a processed Morinda citrifolia product that is used to inhibit aromatase or aromatase enzymes that function to convert androgens to estrogens, inhibit receptors from binding with estrogen, and reduce and/or regulate estrogen production, as well as reduce the amount of estrogen produced within the body and regulating such production. The dietary supplement further provides estrogenic effects. The present invention methods and compositions effectively function to treat estrogen-dependent cancers, and particularly inhibit, destroy, and reverse the effects of of estrogen-dependent cancerous tumors through the introduction into the body (e.g. ingesting) a safe, pre-determined dosage of a naturaceutical composition formulated with or comprising one or more processed Morinda citrifolia products for a safe, pre-determined duration.
摘要翻译：实施的目的是选择性地抑制雌激素产生并在人体内提供雌激素作用。膳食补充剂包括加工的Morinda citrifolia产品，其用于抑制将雄激素转化成雌激素，抑制受体与雌激素结合的芳香酶或芳香酶，以及减少和/或调节雌激素的产生以及减少雌激素的量在体内生产并调节这种生产。膳食补充剂进一步提供雌激素作用。本发明的方法和组合物有效地用于治疗雌激素依赖性癌症，特别是抑制，破坏和逆转雌激素依赖性癌性肿瘤的作用，通过引入体内（例如摄取）安全的预定剂量配制或包含一种或多种加工的Morinda citrifolia产品的保健组合物用于安全的预定持续时间。

10. 外观设计

USD684824S1 Canister 有权
公开(公告)号：USD684824S1
公开(公告)日：2013-06-25
申请号：US29406811
申请日：2011-11-18
申请人： Jared Sweet , Stephen Phung
设计人： Jared Sweet , Stephen Phung

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式